Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s proprietary AccuCinch® Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure.
Location: United States, California, Santa Clara
Employees: 11-50
Total raised: $97.8M
Founded date: 2002
Investors 1
| Date | Name | Website |
| - | Savitr Cap... | savitrcapi... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.07.2021 | - | $80M | - |
| 30.05.2018 | - | $17.8M | - |
Mentions in press and media 6
| Date | Title | Description |
| 21.04.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 21st April 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| 20.04.2023 | Ancora Heart and egnite, Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients | Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network Ancora Heart, a medical device company developing a novel transcatheter d... |
| 20.07.2021 | Ancora Heart Secures $80M Financing | SANTA CLARA, CA, Ancora Heart, a company developing a novel therapy to address heart failure, has closed an $80 million equity financing. >> Click here for more funding data on Ancora Heart >> To export Ancora Heart funding ... |
| 19.07.2021 | Ancora Heart Secures $80 Million in Financing | Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced it has closed an $80 million equity financing. Sands Capital, Sio Capital and an undisclosed strategic investor joined all existing investors... |
| 30.05.2018 | Ancora Heart Raises $17.8M in Funding Round | Ancora Heart, Inc., a Santa Clara, California-based developer of treatments for heart failure, raised $17.8m in a funding round expected to reach $30m. The round was led by Savitr Capital and other existing investors. Led by Jeff Closs, pre... |
| 30.05.2018 | Ancora Heart Lands $17.8M Tranche | SANTA CLARA, CA, Company developing a novel therapy to address heart failure announced the closing of an initial tranche of $17.8 million in a financing round. >> Click here for more funding data on Ancora Heart >> To export... |